Generalizability of the algorithm. Glioma diagnoses depend on molecular features, and therefore, the molecular features are different when considering GBM, which are IDH-wildtype by definition, and other infiltrating gliomas, such as IDH-mutant astrocytomas. This evidence concerns the gene IDH2 and central nervous system cancer.